Lumida
/ICUI
⌘K
ICU Medical Inc

ICU Medical Inc

ICUI
$156.48USD-0.50%-0.78 today

MARKET CAP

3.9B

P/E (TTM)

84.1x

FWD P/E

DAY RANGE

$155 – $162

52W RANGE

$113
$193

AI Summary

Stalk
TrimMedium

Price has decisively broken key support and entered a structured downtrend, with EMAs rolling over and lower highs confirmed. Oversold conditions and extension below the EMA stack suggest caution against immediate selling. Medium-term bias is bearish, so execution should be deferred and focused on pullbacks into the broken support zone near prior resistance.

  • Adjusted EPS $2.37 (+13% YoY) beat estimates; FY26 EPS guidance raised to $8.60–$9.00.
  • Q2 revenue $548M (+1% YoY, +6% organic), adjusted EBITDA $110M (20% margin, +10% YoY).
  • Negative profitability factor indicates ongoing margin pressures and pricing headwinds.
Full analysis →
Insider Trades67 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Aug 13, 2026SellICUIDaniel WoolsonVP, GM-Infusion Capital5,417$181.33$3.9B-18.86%+39.09%$982.3K-24.10%Buy Now
Aug 12, 2026SellICUIBen SousaChief Information Officer2,250$178.32$3.9B-18.86%+39.09%$401.2K-42.25%Buy Now
Aug 11, 2026SellICUIChristian B. VoigtlanderChief Operating Officer8,929$182.93$3.9B-18.86%+39.09%$1.6M-19.28%Buy Now
May 22, 2026SellICUIDaniel WoolsonPresident2,123$132.21$3.9B-18.86%+39.09%$280.7K-8.63%Buy Now
May 14, 2026SellICUIVirginia Ruth SanzoneVP, General Counsel2,447$124.08$3.9B-18.86%+39.09%$303.6K-11.17%Buy Now
Mar 15, 2026SellICUIBen SousaChief Information Officer718$125.85$3.9B-18.86%+39.09%$90.4K-11.88%Buy Now
Mar 15, 2026SellICUIDaniel WoolsonVP, GM-Infusion Capital1,295$125.85$3.9B-18.86%+39.09%$163.0K-5.00%Buy Now
Mar 15, 2026SellICUIVirginia Ruth SanzoneVP, General Counsel4,047$125.85$3.9B-18.86%+39.09%$509.3K-8.59%Buy Now
Mar 15, 2026SellICUIBrian Michael BonnellChief Financial Officer7,595$125.85$3.9B-18.86%+39.09%$955.8K-5.08%Buy Now
Mar 15, 2026SellICUIChristian B. VoigtlanderChief Operating Officer8,096$125.85$3.9B-18.86%+39.09%$1.0M-8.16%Buy Now
Mar 15, 2026SellICUIVivek JainChairman and CEO12,145$125.85$3.9B-18.86%+39.09%$1.5M-4.61%Buy Now
Mar 7, 2026SellICUIBen SousaChief Information Officer5,278$132.00$3.9B-18.86%+39.09%$696.7K-22.04%Buy Now
Mar 7, 2026SellICUIDaniel WoolsonVP, GM-Infusion Capital8,209$132.00$3.9B-18.86%+39.09%$1.1M-10.96%Buy Now
Mar 7, 2026SellICUIVirginia Ruth SanzoneVP, General Counsel16,280$132.00$3.9B-18.86%+39.09%$2.1M-20.98%Buy Now
Mar 7, 2026SellICUIBrian Michael BonnellChief Financial Officer40,930$127.93$3.9B-18.86%+39.09%$5.2M-28.17%Buy Now
Mar 7, 2026SellICUIChristian B. VoigtlanderChief Operating Officer41,613$132.00$3.9B-18.86%+39.09%$5.5M-43.31%Buy Now
Mar 7, 2026SellICUIVivek JainChairman and CEO62,419$125.83$3.9B-18.86%+39.09%$7.9M-24.11%Buy Now
Nov 25, 2025SellICUIDaniel WoolsonVP, GM-Infusion Capital2,897$152.35$3.9B-18.86%+39.09%$441.4K-20.41%Buy Now
Nov 11, 2025SellICUIVirginia Ruth SanzoneVP, General Counsel930$142.34$3.9B-18.86%+39.09%$132.4K-14.56%Buy Now
Sep 12, 2025SellICUIVivek JainChairman and CEO127,282$130.38$3.9B-18.86%+39.09%$16.6M+0.00%Buy Now
Aug 14, 2025BuyICUIVivek JainChairman and CEO21,929$112.84$3.9B-18.86%+39.09%$2.5M+10.02%Buy Now
May 30, 2025SellICUIVirginia Ruth SanzoneVP, General Counsel700$133.62$3.9B-18.86%+39.09%$93.5K-9.88%Buy Now
May 27, 2025BuyICUIChristian B. VoigtlanderChief Operating Officer21,045$112.36$3.9B-18.86%+39.09%$2.4M+3.16%Buy Now
May 22, 2025BuyICUIChristian B. VoigtlanderChief Operating Officer21,028$112.48$3.9B-18.86%+39.09%$2.4M+2.17%Buy Now
May 20, 2025BuyICUIChristian B. VoigtlanderChief Operating Officer20,898$114.73$3.9B-18.86%+39.09%$2.4M+1.84%Buy Now
May 16, 2025SellICUIChristian B. VoigtlanderChief Operating Officer22,220$117.92$3.9B-18.86%+39.09%$2.6M+0.00%Buy Now
May 15, 2025SellICUIBen SousaChief Information Officer2,000$137.36$3.9B-18.86%+39.09%$274.7K-80.68%Buy Now
May 14, 2025SellICUIChristian B. VoigtlanderChief Operating Officer22,222$116.96$3.9B-18.86%+39.09%$2.6M+0.00%Buy Now
Mar 15, 2025SellICUIBen SousaChief Information Officer716$143.45$3.9B-18.86%+39.09%$102.7K-15.93%Buy Now
Mar 15, 2025SellICUIVirginia Ruth SanzoneVP, General Counsel898$143.45$3.9B-18.86%+39.09%$128.8K-9.35%Buy Now
Mar 15, 2025SellICUIDaniel WoolsonVP, GM-Infusion Capital1,294$143.45$3.9B-18.86%+39.09%$185.6K-7.03%Buy Now
Mar 15, 2025SellICUIChristian B. VoigtlanderChief Operating Officer1,792$143.45$3.9B-18.86%+39.09%$257.1K-24.12%Buy Now
Mar 15, 2025SellICUIVivek JainChairman and CEO2,688$143.45$3.9B-18.86%+39.09%$385.6K-2.32%Buy Now
Mar 7, 2025SellICUIBen SousaChief Information Officer810$141.97$3.9B-18.86%+39.09%$115.0K-4.65%Buy Now
Mar 7, 2025SellICUIChristian B. VoigtlanderChief Operating Officer1,213$141.97$3.9B-18.86%+39.09%$172.2K-9.54%Buy Now
Mar 7, 2025SellICUIDaniel WoolsonVP, GM-Infusion Capital1,420$141.97$3.9B-18.86%+39.09%$201.6K-3.11%Buy Now
Mar 7, 2025SellICUIVivek JainChairman and CEO1,775$141.97$3.9B-18.86%+39.09%$252.0K-1.70%Buy Now
Mar 7, 2025SellICUIVirginia Ruth SanzoneVP, General Counsel2,384$141.97$3.9B-18.86%+39.09%$338.5K-5.45%Buy Now
Jan 2, 2025SellICUIVivek JainChairman and CEO2,746$122.12$3.9B-18.86%+39.09%$335.3K+0.00%Buy Now
Dec 6, 2024SellICUIDaniel WoolsonVP, GM-Infusion Capital2,241$156.25$3.9B-18.86%+39.09%$350.2K-17.10%Buy Now
Dec 2, 2024SellICUIVivek JainChairman and CEO24,000$125.84$3.9B-18.86%+39.09%$3.0M+0.00%Buy Now
Nov 27, 2024SellICUIChristian B. VoigtlanderChief Operating Officer2,860$127.41$3.9B-18.86%+39.09%$364.4K+0.00%Buy Now
Nov 25, 2024SellICUIChristian B. VoigtlanderChief Operating Officer19,362$128.98$3.9B-18.86%+39.09%$2.5M+0.00%Buy Now
Nov 1, 2024SellICUIVivek JainChairman and CEO24,000$130.30$3.9B-18.86%+39.09%$3.1M+0.00%Buy Now
Oct 1, 2024SellICUIVivek JainChairman and CEO24,000$133.61$3.9B-18.86%+39.09%$3.2M+0.00%Buy Now
Sep 3, 2024SellICUIVivek JainChairman and CEO24,000$126.11$3.9B-18.86%+39.09%$3.0M+0.00%Buy Now
Aug 30, 2024SellICUIDaniel WoolsonVP, GM-Infusion Capital2,502$163.22$3.9B-18.86%+39.09%$408.4K-16.03%Buy Now
Aug 16, 2024SellICUIVivek JainChairman and CEO24,000$122.40$3.9B-18.86%+39.09%$2.9M+0.00%Buy Now
Aug 8, 2024SellICUIVirginia Ruth SanzoneVP, General Counsel2,050$144.11$3.9B-18.86%+39.09%$295.4K-31.38%10b5-1Buy Now
May 30, 2024SellICUIChristian B. VoigtlanderChief Operating Officer12,539$103.95$3.9B-18.86%+39.09%$1.3M-86.05%Buy Now
May 10, 2024SellICUIBen SousaChief Information Officer2,000$105.55$3.9B-18.86%+39.09%$211.1K-60.26%Buy Now
Mar 15, 2024SellICUIBen SousaChief Information Officer463$98.08$3.9B-18.86%+39.09%$45.4K-7.26%Buy Now
Mar 15, 2024SellICUIDaniel WoolsonVP, GM-Infusion Capital791$98.27$3.9B-18.86%+39.09%$77.7K-5.36%Buy Now
Mar 15, 2024SellICUIVirginia Ruth SanzoneVP, General Counsel890$98.08$3.9B-18.86%+39.09%$87.3K-8.34%Buy Now
Mar 15, 2024SellICUIDaniel WoolsonVP, GM-Infusion Capital1,294$98.08$3.9B-18.86%+39.09%$126.9K-5.69%Buy Now
Mar 15, 2024SellICUIBrian Michael BonnellChief Financial Officer1,780$98.08$3.9B-18.86%+39.09%$174.6K-5.36%Buy Now
Mar 15, 2024SellICUIChristian B. VoigtlanderChief Operating Officer1,780$98.08$3.9B-18.86%+39.09%$174.6K-8.55%Buy Now
Mar 15, 2024SellICUIVivek JainChairman and CEO2,671$98.08$3.9B-18.86%+39.09%$262.0K-2.28%Buy Now
Mar 7, 2024SellICUIBen SousaChief Information Officer1,317$105.23$3.9B-18.86%+39.09%$138.6K-13.80%Buy Now
Mar 7, 2024SellICUIDaniel WoolsonVP, GM-Infusion Capital3,884$105.19$3.9B-18.86%+39.09%$408.6K-7.75%Buy Now
Mar 7, 2024SellICUIVirginia Ruth SanzoneVP, General Counsel8,662$104.95$3.9B-18.86%+39.09%$909.1K-20.09%Buy Now
Mar 7, 2024SellICUIBrian Michael BonnellChief Financial Officer13,444$105.05$3.9B-18.86%+39.09%$1.4M-14.64%Buy Now
Mar 7, 2024SellICUIChristian B. VoigtlanderChief Operating Officer13,444$105.05$3.9B-18.86%+39.09%$1.4M-31.86%Buy Now
Mar 7, 2024SellICUIVivek JainChairman and CEO18,305$105.11$3.9B-18.86%+39.09%$1.9M-4.48%Buy Now
Mar 4, 2024SellICUIChristian B. VoigtlanderChief Operating Officer13,603$107.19$3.9B-18.86%+39.09%$1.5M-66.23%Buy Now
Feb 12, 2024BuyICUIVivek JainChairman and CEO332,393$75.12$3.9B-18.86%+39.09%$25.0M+24.32%Buy Now
Dec 1, 2023SellICUIDaniel WoolsonVP, GM-Infusion Capital1,729$88.03$3.9B-18.86%+39.09%$152.2K-14.90%Buy Now